| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | dimeric IgA immunoglobulin complex | 3.50e-05 | 3 | 72 | 2 | GO:0071750 | |
| GeneOntologyCellularComponent | secretory dimeric IgA immunoglobulin complex | 3.50e-05 | 3 | 72 | 2 | GO:0071752 | |
| GeneOntologyCellularComponent | monomeric IgA immunoglobulin complex | 4.15e-04 | 9 | 72 | 2 | GO:0071748 | |
| GeneOntologyCellularComponent | polymeric IgA immunoglobulin complex | 5.17e-04 | 10 | 72 | 2 | GO:0071749 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex, circulating | 5.17e-04 | 10 | 72 | 2 | GO:0071746 | |
| GeneOntologyCellularComponent | secretory IgA immunoglobulin complex | 5.17e-04 | 10 | 72 | 2 | GO:0071751 | |
| GeneOntologyCellularComponent | Golgi lumen | 5.48e-04 | 109 | 72 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex | 1.19e-03 | 15 | 72 | 2 | GO:0071745 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 1.54e-03 | 17 | 72 | 2 | GO:0042571 | |
| Domain | DUF4599 | 1.13e-05 | 12 | 71 | 3 | PF15371 | |
| Domain | DUF4599 | 1.13e-05 | 12 | 71 | 3 | IPR027970 | |
| Domain | M_domain | 1.42e-05 | 2 | 71 | 2 | PF12938 | |
| Domain | GW182_M_dom | 1.42e-05 | 2 | 71 | 2 | IPR026805 | |
| Domain | Ago_hook | 4.26e-05 | 3 | 71 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 4.26e-05 | 3 | 71 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 4.26e-05 | 3 | 71 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 4.26e-05 | 3 | 71 | 2 | PF16608 | |
| Domain | WxxW_domain | 2.12e-04 | 6 | 71 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 2.12e-04 | 6 | 71 | 2 | PF13330 | |
| Domain | TIL | 9.18e-04 | 12 | 71 | 2 | PF01826 | |
| Domain | C8 | 9.18e-04 | 12 | 71 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.08e-03 | 13 | 71 | 2 | IPR014853 | |
| Domain | C8 | 1.08e-03 | 13 | 71 | 2 | SM00832 | |
| Domain | SEA | 1.26e-03 | 14 | 71 | 2 | SM00200 | |
| Domain | TIL_dom | 1.26e-03 | 14 | 71 | 2 | IPR002919 | |
| Domain | RRM | 1.41e-03 | 217 | 71 | 5 | SM00360 | |
| Domain | Glyco_hormone_CN | 1.45e-03 | 15 | 71 | 2 | IPR006208 | |
| Domain | Cys_knot | 1.45e-03 | 15 | 71 | 2 | PF00007 | |
| Domain | VWD | 1.65e-03 | 16 | 71 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.65e-03 | 16 | 71 | 2 | IPR001846 | |
| Domain | VWFD | 1.65e-03 | 16 | 71 | 2 | PS51233 | |
| Domain | VWD | 1.65e-03 | 16 | 71 | 2 | PF00094 | |
| Domain | RRM_dom | 1.72e-03 | 227 | 71 | 5 | IPR000504 | |
| Domain | UBA-like | 1.86e-03 | 64 | 71 | 3 | IPR009060 | |
| Domain | CH | 1.94e-03 | 65 | 71 | 3 | SM00033 | |
| Domain | CTCK_1 | 2.10e-03 | 18 | 71 | 2 | PS01185 | |
| Domain | VWC_out | 2.34e-03 | 19 | 71 | 2 | SM00215 | |
| Domain | - | 2.36e-03 | 244 | 71 | 5 | 3.30.70.330 | |
| Domain | CH | 2.40e-03 | 70 | 71 | 3 | PF00307 | |
| Domain | - | 2.50e-03 | 71 | 71 | 3 | 1.10.418.10 | |
| Domain | CH | 2.71e-03 | 73 | 71 | 3 | PS50021 | |
| Domain | - | 2.86e-03 | 21 | 71 | 2 | 1.10.720.30 | |
| Domain | CH-domain | 2.92e-03 | 75 | 71 | 3 | IPR001715 | |
| Domain | Nucleotide-bd_a/b_plait | 3.00e-03 | 258 | 71 | 5 | IPR012677 | |
| Domain | CT | 3.13e-03 | 22 | 71 | 2 | SM00041 | |
| Domain | SAP | 3.13e-03 | 22 | 71 | 2 | PF02037 | |
| Domain | SAP | 3.42e-03 | 23 | 71 | 2 | SM00513 | |
| Domain | SEA | 3.42e-03 | 23 | 71 | 2 | PS50024 | |
| Domain | SEA_dom | 3.42e-03 | 23 | 71 | 2 | IPR000082 | |
| Domain | SAP | 4.04e-03 | 25 | 71 | 2 | PS50800 | |
| Domain | Cys_knot_C | 4.04e-03 | 25 | 71 | 2 | IPR006207 | |
| Domain | SAP_dom | 4.04e-03 | 25 | 71 | 2 | IPR003034 | |
| Domain | CTCK_2 | 4.04e-03 | 25 | 71 | 2 | PS01225 | |
| Domain | VWC | 5.05e-03 | 28 | 71 | 2 | PF00093 | |
| Domain | UBA | 5.79e-03 | 30 | 71 | 2 | SM00165 | |
| Domain | LRRCT | 6.57e-03 | 32 | 71 | 2 | PF01463 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.46e-07 | 16 | 44 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.91e-07 | 17 | 44 | 4 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 7.00e-07 | 23 | 44 | 4 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 1.17e-06 | 26 | 44 | 4 | M27483 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.63e-05 | 21 | 44 | 3 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 4.04e-05 | 62 | 44 | 4 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.81e-05 | 68 | 44 | 4 | M27303 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.98e-04 | 7 | 44 | 2 | M46421 | |
| Pathway | REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING | 2.63e-04 | 8 | 44 | 2 | M27351 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 3.38e-04 | 9 | 44 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 3.38e-04 | 9 | 44 | 2 | M46436 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.88e-04 | 111 | 44 | 4 | M27416 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 4.22e-04 | 10 | 44 | 2 | M48013 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 4.74e-04 | 117 | 44 | 4 | M19248 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 7.27e-04 | 13 | 44 | 2 | M46434 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 7.77e-04 | 58 | 44 | 3 | M11980 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 8.57e-04 | 60 | 44 | 3 | MM15636 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 9.30e-04 | 140 | 44 | 4 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.01e-03 | 143 | 44 | 4 | M27275 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 1.26e-03 | 17 | 44 | 2 | M27788 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 1.36e-03 | 155 | 44 | 4 | M522 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 1.57e-03 | 19 | 44 | 2 | M48238 | |
| Pathway | PID_P73PATHWAY | 1.90e-03 | 79 | 44 | 3 | M19 | |
| Pubmed | USP31 UBE4B UBAP2L ATG13 ZNF423 SPHKAP ACIN1 NLGN1 TNRC6C PLCE1 | 1.21e-08 | 407 | 72 | 10 | 12693553 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO3 USP31 SASH1 LIMD1 MTUS1 ERCC6L ATG13 NECTIN2 NAV2 CLASP2 PLEC PPIP5K2 EPN2 | 2.21e-08 | 861 | 72 | 13 | 36931259 |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 5.05e-08 | 18 | 72 | 4 | 18834073 | |
| Pubmed | 1.69e-07 | 6 | 72 | 3 | 19110483 | ||
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 1.27e-06 | 90 | 72 | 5 | 35654790 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | FOXO3 TMEM201 LIMD1 BRCA2 MTUS1 ATG13 PKP4 TNRC6A TNRC6C PLEC PPIP5K2 | 1.40e-06 | 853 | 72 | 11 | 28718761 |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 7513696 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 34058148 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 37146737 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 4.23e-06 | 2 | 72 | 2 | 14988081 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 15563276 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 18782111 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 17621824 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 2241915 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 22220206 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 24317696 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 22391959 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 14718370 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 4.23e-06 | 2 | 72 | 2 | 35776514 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 24327612 | ||
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 4.23e-06 | 2 | 72 | 2 | 21653907 | |
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 4.23e-06 | 2 | 72 | 2 | 36427316 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 27656835 | ||
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 4.23e-06 | 2 | 72 | 2 | 28607090 | |
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 4.23e-06 | 2 | 72 | 2 | 23272068 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 31030254 | ||
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 4.23e-06 | 2 | 72 | 2 | 27729120 | |
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 4.23e-06 | 2 | 72 | 2 | 23527003 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 16540890 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 36111525 | ||
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 4.23e-06 | 2 | 72 | 2 | 27845589 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 27435107 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 26871672 | ||
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 4.23e-06 | 2 | 72 | 2 | 32348677 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 19709076 | ||
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 4.23e-06 | 2 | 72 | 2 | 11587997 | |
| Pubmed | Maternal Hypertension-Related Genotypes and Congenital Heart Defects. | 4.23e-06 | 2 | 72 | 2 | 32710738 | |
| Pubmed | Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. | 4.23e-06 | 2 | 72 | 2 | 24722639 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 4.23e-06 | 2 | 72 | 2 | 24332705 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 4.23e-06 | 2 | 72 | 2 | 34656442 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOXO3 USF3 PWWP2B AKIRIN1 LIMD1 UBE4B UBAP2L ATG13 NECTIN2 UBA6 CLASP2 TNRC6C CAP2 | 1.04e-05 | 1489 | 72 | 13 | 28611215 |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 33232357 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 27776277 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 29286856 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 27230679 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 36675209 | ||
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 1.27e-05 | 3 | 72 | 2 | 18163520 | |
| Pubmed | Cigarette smoke augments MUC5AC production via the TLR3-EGFR pathway in airway epithelial cells. | 1.27e-05 | 3 | 72 | 2 | 26100173 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 29802623 | ||
| Pubmed | Autophagy of mucin granules contributes to resolution of airway mucous metaplasia. | 1.27e-05 | 3 | 72 | 2 | 34158522 | |
| Pubmed | Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. | 1.27e-05 | 3 | 72 | 2 | 34108231 | |
| Pubmed | Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. | 1.27e-05 | 3 | 72 | 2 | 29604272 | |
| Pubmed | IL-8 regulates mucin gene expression at the posttranscriptional level in lung epithelial cells. | 1.27e-05 | 3 | 72 | 2 | 19596978 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 24220028 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 16880270 | ||
| Pubmed | Regulation of neuregulin 1beta1-induced MUC5AC and MUC5B expression in human airway epithelium. | 1.27e-05 | 3 | 72 | 2 | 19556605 | |
| Pubmed | Aquaporin 5 expression increases mucin production in lung adenocarcinoma. | 1.27e-05 | 3 | 72 | 2 | 21455588 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 31670606 | ||
| Pubmed | Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue. | 1.27e-05 | 3 | 72 | 2 | 20422702 | |
| Pubmed | Rhinovirus-induced major airway mucin production involves a novel TLR3-EGFR-dependent pathway. | 1.27e-05 | 3 | 72 | 2 | 18978302 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 19718741 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FOXO3 CRYBG2 HEG1 PWWP2B UBE4B NAV2 CARD10 CLASP2 TNRC6C PLEC ADCY7 | 1.63e-05 | 1105 | 72 | 11 | 35748872 |
| Pubmed | ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites. | 2.53e-05 | 4 | 72 | 2 | 31582416 | |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 24145934 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 25638393 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 17471237 | ||
| Pubmed | MCP-1/CCR2B-dependent loop upregulates MUC5AC and MUC5B in human airway epithelium. | 2.53e-05 | 4 | 72 | 2 | 21097527 | |
| Pubmed | Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast. | 2.53e-05 | 4 | 72 | 2 | 22269464 | |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 14984930 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 23249391 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 23172285 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 2.53e-05 | 4 | 72 | 2 | 29869461 | |
| Pubmed | Munc13-2-/- baseline secretion defect reveals source of oligomeric mucins in mouse airways. | 2.53e-05 | 4 | 72 | 2 | 18258655 | |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 33362245 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 23807779 | ||
| Pubmed | Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathy. | 2.53e-05 | 4 | 72 | 2 | 23398317 | |
| Pubmed | Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. | 2.53e-05 | 4 | 72 | 2 | 21063388 | |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 20181956 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 12676567 | ||
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 4.21e-05 | 5 | 72 | 2 | 11062147 | |
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 6421489 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 23250751 | ||
| Pubmed | Differential expression of MUC genes in endometrial and cervical tissues and tumors. | 4.21e-05 | 5 | 72 | 2 | 16188033 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 5.62e-05 | 322 | 72 | 6 | 39098523 | |
| Pubmed | 5.78e-05 | 36 | 72 | 3 | 15745951 | ||
| Pubmed | 6.15e-05 | 102 | 72 | 4 | 9734811 | ||
| Pubmed | 6.29e-05 | 481 | 72 | 7 | 28190767 | ||
| Pubmed | 6.31e-05 | 6 | 72 | 2 | 20850414 | ||
| Pubmed | 6.31e-05 | 6 | 72 | 2 | 29742426 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 6.31e-05 | 6 | 72 | 2 | 25930072 | |
| Pubmed | ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2. | 6.81e-05 | 38 | 72 | 3 | 30629181 | |
| Pubmed | 8.82e-05 | 7 | 72 | 2 | 28683311 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 8.82e-05 | 7 | 72 | 2 | 19470757 | |
| Pubmed | 8.82e-05 | 7 | 72 | 2 | 19383768 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 9.19e-05 | 218 | 72 | 5 | 33378226 | |
| Pubmed | 1.17e-04 | 8 | 72 | 2 | 21802298 | ||
| Pubmed | 1.17e-04 | 8 | 72 | 2 | 24768540 | ||
| Pubmed | 1.51e-04 | 9 | 72 | 2 | 32869873 | ||
| Pubmed | LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing. | 1.51e-04 | 9 | 72 | 2 | 20616046 | |
| Pubmed | USP31 GABRG2 UBAP2L CRACDL PKP4 CPEB4 USP4 CLASP2 PLEC CNTN2 EPN2 | 1.66e-04 | 1431 | 72 | 11 | 37142655 | |
| Interaction | HBM interactions | 1.96e-06 | 27 | 68 | 4 | int:HBM | |
| Interaction | SFN interactions | FOXO3 USP31 SASH1 MTUS1 ERCC6L ATG13 NAV2 ZFYVE19 USP4 CLASP2 PLEC SMTNL2 | 3.05e-06 | 692 | 68 | 12 | int:SFN |
| Interaction | YWHAH interactions | FOXO3 USP31 SASH1 LIMD1 MTUS1 ERCC6L ATG13 NECTIN2 NAV2 USP4 CLASP2 PLEC PPIP5K2 EPN2 SMTNL2 | 3.06e-06 | 1102 | 68 | 15 | int:YWHAH |
| Interaction | USP53 interactions | 7.14e-06 | 138 | 68 | 6 | int:USP53 | |
| Interaction | CNOT6L interactions | 1.56e-05 | 93 | 68 | 5 | int:CNOT6L | |
| Interaction | TWF1 interactions | 2.50e-05 | 172 | 68 | 6 | int:TWF1 | |
| Interaction | SPNS3 interactions | 4.68e-05 | 21 | 68 | 3 | int:SPNS3 | |
| Interaction | EBF2 interactions | 4.69e-05 | 59 | 68 | 4 | int:EBF2 | |
| Interaction | YWHAG interactions | FOXO3 USP31 SASH1 LIMD1 MTUS1 ERCC6L ATG13 NECTIN2 NAV2 ACIN1 CLASP2 PPIP5K2 EPN2 SMTNL2 | 5.97e-05 | 1248 | 68 | 14 | int:YWHAG |
| Interaction | FANCM interactions | 6.47e-05 | 64 | 68 | 4 | int:FANCM | |
| Interaction | PAN3 interactions | 6.87e-05 | 65 | 68 | 4 | int:PAN3 | |
| Interaction | PLEC interactions | 9.71e-05 | 430 | 68 | 8 | int:PLEC | |
| Interaction | TNRC6C interactions | 1.03e-04 | 138 | 68 | 5 | int:TNRC6C | |
| Interaction | YWHAZ interactions | FOXO3 USP31 SASH1 MTUS1 IGHA2 ATG13 NECTIN2 NAV2 ZFYVE19 CLASP2 PLEC PPIP5K2 EPN2 SMTNL2 | 1.08e-04 | 1319 | 68 | 14 | int:YWHAZ |
| Interaction | GPBP1 interactions | 1.20e-04 | 75 | 68 | 4 | int:GPBP1 | |
| Cytoband | 3p21.3 | 1.13e-04 | 59 | 72 | 3 | 3p21.3 | |
| Cytoband | Xp22.11 | 5.00e-04 | 21 | 72 | 2 | Xp22.11 | |
| GeneFamily | CD molecules|Mucins | 1.94e-07 | 21 | 45 | 4 | 648 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.75e-03 | 25 | 45 | 2 | 775 | |
| Coexpression | GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP | 1.19e-06 | 200 | 71 | 7 | M7478 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.02e-07 | 197 | 72 | 6 | d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.02e-07 | 197 | 72 | 6 | 80b05c8ad9c1edc5dea3236079372475431343fe | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.53e-06 | 175 | 72 | 5 | 19eda8b5d39dc93d79737ebdbeeba5ec0cb23c51 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 177 | 72 | 5 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 177 | 72 | 5 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.03e-05 | 178 | 72 | 5 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-05 | 178 | 72 | 5 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-05 | 178 | 72 | 5 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.03e-05 | 178 | 72 | 5 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 72 | 5 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 72 | 5 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.28e-05 | 186 | 72 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-05 | 192 | 72 | 5 | 8899d81306770adda893b5e146df1253971754c5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-05 | 192 | 72 | 5 | 5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 193 | 72 | 5 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.53e-05 | 193 | 72 | 5 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.53e-05 | 193 | 72 | 5 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 194 | 72 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 194 | 72 | 5 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 194 | 72 | 5 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-05 | 195 | 72 | 5 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 196 | 72 | 5 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 196 | 72 | 5 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.69e-05 | 197 | 72 | 5 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.77e-05 | 199 | 72 | 5 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | COVID-19_Severe-MAIT|World / disease group, cell group and cell class | 8.98e-05 | 145 | 72 | 4 | 8d63f97812f63329ef9c940b291dc5a1c4d90690 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-04 | 155 | 72 | 4 | 62b59cb32b12bd55b19e98786a866d788fc9e4bf | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-04 | 160 | 72 | 4 | 028b5261a1da832d52f66fb620db83e5fbbd874a | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-04 | 160 | 72 | 4 | 1f4ee446436726c3d373f56d87dd80b6a12e8b9e | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.73e-04 | 172 | 72 | 4 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 173 | 72 | 4 | f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4 | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.81e-04 | 174 | 72 | 4 | f1510b0f7771936adf29ae3572feab55db31832b | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.81e-04 | 174 | 72 | 4 | 5d5d2fc60afff47f997751e8e9ca1367a22d19ec | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-04 | 176 | 72 | 4 | 95d5a4fdff1b9c715636684d22e06f8727ac0e7a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-04 | 179 | 72 | 4 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.02e-04 | 179 | 72 | 4 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.02e-04 | 179 | 72 | 4 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.02e-04 | 179 | 72 | 4 | 3b0f8781232e1d42b6f8913bc989a14b3f978e79 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.06e-04 | 180 | 72 | 4 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.06e-04 | 180 | 72 | 4 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.06e-04 | 180 | 72 | 4 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.06e-04 | 180 | 72 | 4 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | Control-Myeloid-DC1|Control / Condition, Lineage and Cell class | 2.11e-04 | 181 | 72 | 4 | 5a2a1f017ad23baed9972c68b4a46f4c618ef21a | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 182 | 72 | 4 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 182 | 72 | 4 | ffe500d78a89dc6b4d05bab1664e7f30c94fb8d9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 182 | 72 | 4 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 2.20e-04 | 183 | 72 | 4 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 184 | 72 | 4 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | Control-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class | 2.24e-04 | 184 | 72 | 4 | b5c1f57f0356969cfb0e1dac764684fc5583bc04 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 2.24e-04 | 184 | 72 | 4 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-04 | 185 | 72 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Severe-B_memory-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.29e-04 | 185 | 72 | 4 | 0a2a3acc8747f4ad8c4d37e76378cca6852b9952 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-04 | 185 | 72 | 4 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-04 | 185 | 72 | 4 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 2.34e-04 | 186 | 72 | 4 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 187 | 72 | 4 | 74112df9b34051ae5cd2427ccfa3399eccff0076 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 187 | 72 | 4 | 214ce9b55fd6ce2fe7bd4cf4b1383517f5f0d759 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.43e-04 | 188 | 72 | 4 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-04 | 188 | 72 | 4 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.43e-04 | 188 | 72 | 4 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-04 | 188 | 72 | 4 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 2.48e-04 | 189 | 72 | 4 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.48e-04 | 189 | 72 | 4 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.48e-04 | 189 | 72 | 4 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-04 | 190 | 72 | 4 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-04 | 190 | 72 | 4 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.53e-04 | 190 | 72 | 4 | a1514d2186eb4fe569971ab22dc0c17d353fb94a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.53e-04 | 190 | 72 | 4 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Mesenchymal_cells-Smooth_muscle|World / Lineage and Cell class | 2.53e-04 | 190 | 72 | 4 | 5aa62a363a25f4a110136263b21289a11e8c1e6d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-04 | 190 | 72 | 4 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-04 | 190 | 72 | 4 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.53e-04 | 190 | 72 | 4 | 0bb954a94317cfc742b9b6221bb80f8baa6d3ff1 | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 2.53e-04 | 190 | 72 | 4 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-04 | 190 | 72 | 4 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 2.53e-04 | 190 | 72 | 4 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | IPF-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 2.53e-04 | 190 | 72 | 4 | c29dabf0826663b9d6df51a7af9b76592090e44c | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.53e-04 | 190 | 72 | 4 | 26e2237f65cb43723c5da853831b40df2982d6e4 | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC3|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.58e-04 | 191 | 72 | 4 | 6eaf72b41084404bee0db04e4605db745a74995f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-04 | 191 | 72 | 4 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 191 | 72 | 4 | cb75e6c36dbe2e091e407d691c063ec7c4fd5f90 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 191 | 72 | 4 | b2cffea7860dd590b505ee0ebd51aa1978cb5e64 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 2.64e-04 | 192 | 72 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 2.64e-04 | 192 | 72 | 4 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.64e-04 | 192 | 72 | 4 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 2.64e-04 | 192 | 72 | 4 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 2.64e-04 | 192 | 72 | 4 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 192 | 72 | 4 | e5117cdb8af220f60bd1410262078c0306667b4a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-04 | 192 | 72 | 4 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | 15|World / Age, Tissue, Lineage and Cell class | 2.69e-04 | 193 | 72 | 4 | a8ad0de955494d6f5929dc44ba46627d06d95453 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-04 | 193 | 72 | 4 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | COVID-19_Severe-CD8+_T_activated|World / disease group, cell group and cell class | 2.69e-04 | 193 | 72 | 4 | ddc1db516568e03be8e82b2ca770c67756418185 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-04 | 193 | 72 | 4 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | IPF-Endothelial-VE_Arterial|IPF / Disease state, Lineage and Cell class | 2.69e-04 | 193 | 72 | 4 | bf83b1fe9d38408f30eee4eb634341c04ef82791 | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-04 | 193 | 72 | 4 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.69e-04 | 193 | 72 | 4 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-04 | 194 | 72 | 4 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-04 | 194 | 72 | 4 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.80e-04 | 195 | 72 | 4 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.80e-04 | 195 | 72 | 4 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.80e-04 | 195 | 72 | 4 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| Computational | Genes in the cancer module 257. | 2.89e-05 | 156 | 42 | 6 | MODULE_257 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.66e-05 | 64 | 70 | 4 | DOID:4947 (is_marker_for) | |
| Disease | keratoconjunctivitis (is_marker_for) | 1.66e-05 | 3 | 70 | 2 | DOID:9368 (is_marker_for) | |
| Disease | COVID-19 symptoms measurement | 7.92e-05 | 35 | 70 | 3 | EFO_0600019 | |
| Disease | MEDULLOBLASTOMA | 8.27e-05 | 6 | 70 | 2 | 155255 | |
| Disease | Medulloblastoma | 8.27e-05 | 6 | 70 | 2 | cv:C0025149 | |
| Disease | renal overload-type gout | 8.27e-05 | 6 | 70 | 2 | EFO_0021525 | |
| Disease | visceral adipose tissue measurement | 1.45e-04 | 481 | 70 | 7 | EFO_0004765 | |
| Disease | eosinophil cationic protein measurement | 1.54e-04 | 8 | 70 | 2 | EFO_0010913 | |
| Disease | Glioma | 1.98e-04 | 9 | 70 | 2 | cv:C0017638 | |
| Disease | longitudinal alcohol consumption measurement | 1.98e-04 | 9 | 70 | 2 | EFO_0007645 | |
| Disease | pursuit maintenance gain measurement | 2.13e-04 | 123 | 70 | 4 | EFO_0008433 | |
| Disease | medulloblastoma (is_implicated_in) | 2.47e-04 | 10 | 70 | 2 | DOID:0050902 (is_implicated_in) | |
| Disease | dry eye syndrome (is_marker_for) | 2.47e-04 | 10 | 70 | 2 | DOID:10140 (is_marker_for) | |
| Disease | pulmonary fibrosis | 3.01e-04 | 11 | 70 | 2 | EFO_0009448 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 4.17e-04 | 61 | 70 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Antihypertensive use measurement | 4.23e-04 | 265 | 70 | 5 | EFO_0009927 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 4.25e-04 | 13 | 70 | 2 | C0751122 | |
| Disease | egg allergy measurement, parental genotype effect measurement | 4.25e-04 | 13 | 70 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | cup-to-disc ratio measurement | 5.52e-04 | 430 | 70 | 6 | EFO_0006939 | |
| Disease | amygdala volume change measurement | 6.52e-04 | 16 | 70 | 2 | EFO_0021490 | |
| Disease | body weight | FOXO3 USF3 ZNF423 SPHKAP CPEB4 TNRC6A SPATA31C2 NLGN1 SPATA31C1 TPBG | 7.54e-04 | 1261 | 70 | 10 | EFO_0004338 |
| Disease | body surface area | 8.25e-04 | 643 | 70 | 7 | EFO_0022196 | |
| Disease | DNA methylation | 9.27e-04 | 656 | 70 | 7 | GO_0006306 | |
| Disease | body fat percentage | 1.06e-03 | 488 | 70 | 6 | EFO_0007800 | |
| Disease | mean arterial pressure | 1.19e-03 | 499 | 70 | 6 | EFO_0006340 | |
| Disease | cortical thickness | 1.23e-03 | 1113 | 70 | 9 | EFO_0004840 | |
| Disease | Sjogren's syndrome (is_marker_for) | 1.48e-03 | 24 | 70 | 2 | DOID:12894 (is_marker_for) | |
| Disease | smoking status measurement | 1.64e-03 | 1160 | 70 | 9 | EFO_0006527 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.74e-03 | 364 | 70 | 5 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | smoking behaviour measurement | 1.94e-03 | 222 | 70 | 4 | EFO_0005671 | |
| Disease | risk-taking behaviour | 2.21e-03 | 764 | 70 | 7 | EFO_0008579 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSIASTSSTEKSFPW | 76 | Q99569 | |
| WGASTATTQKKPSIS | 851 | Q9UKV3 | |
| SSALTAPSSPGSSWM | 111 | Q9H9L7 | |
| SVTLKPWSPGLSSSS | 556 | Q9BWT7 | |
| LSSSSSSDSVWPLGK | 566 | Q9BWT7 | |
| KICTRSSSSPTGSDW | 36 | O75143 | |
| NGTTSGTPSCSWKDL | 781 | P51828 | |
| VLTRGSSANASKWSP | 131 | Q96K21 | |
| SFTAIPSSSLGTTWT | 2536 | Q9HC84 | |
| SFTAIPSSSLGTTWT | 4521 | Q9HC84 | |
| SSSPNLTSPATKAWT | 1371 | Q8WXI7 | |
| DINLESGTTSSPSWK | 3911 | Q8WXI7 | |
| SAPTLDTSATASWTG | 4106 | Q8WXI7 | |
| DTSATASWTGTPLAT | 4111 | Q8WXI7 | |
| TFTLDSSSTASWPGT | 9381 | Q8WXI7 | |
| GSRKSISNSHLSWST | 2366 | Q5D862 | |
| SEKPTGLWSTASSQR | 256 | Q9UGP4 | |
| SSGKPTSLKTAQSSW | 761 | Q9ULD2 | |
| SDAWGAVSTTKPVSV | 426 | O95208 | |
| GLTWSKTGPVASTVS | 206 | P40123 | |
| WTSAGSLNSVPTNSA | 731 | Q86XP3 | |
| SPWATGTLSTATSIS | 16 | Q02505 | |
| ATTPASTWDSTAAGL | 291 | Q2VPJ9 | |
| RATSPTQSTSSWQKS | 2236 | P98088 | |
| GRATSPTQSTSSWQK | 3341 | P98088 | |
| ATSPTQSTSSWQKSR | 3641 | P98088 | |
| LLKSTSDASTPWSSS | 701 | Q9ULI3 | |
| SGTALSSWAVSFQPA | 336 | Q8N2Q7 | |
| PSSTGSSTWKQSQTR | 46 | Q6NV74 | |
| TNPSSSGKSATWQKS | 881 | Q5T6X5 | |
| AWDTVASTPGTSKTT | 216 | Q8WWV6 | |
| GTSWKSPGRSFQVSS | 311 | Q9H5Z6 | |
| GSWPATTTQNSVALK | 561 | P51587 | |
| VQGSSASAASSPTWK | 481 | Q8N1P7 | |
| SGVTFTWTPSSGKSA | 156 | P01876 | |
| MSSPNIWSTGSSVYS | 1 | P18507 | |
| PGNISWTFSSSSLSI | 916 | Q02246 | |
| ASEALWGKSSVSPSL | 291 | Q8N6U8 | |
| TGFSNWSAAIAPSSS | 166 | Q17RY0 | |
| TFTWTPSSGKSAVQG | 146 | P01877 | |
| TPTATAETCWKGTSS | 41 | O00321 | |
| KGTSSSLASFPQLDW | 51 | O00321 | |
| AGSSSPSQPTWKSSL | 31 | Q9Y238 | |
| AKVSWFGSPTTSFLS | 526 | Q6NUJ5 | |
| SWAKSIPGFSSLSLS | 241 | P11474 | |
| PSGETLSSENKSSWL | 1146 | Q2NKX8 | |
| TSTSALSPGSKPSTW | 206 | O75807 | |
| SSSTPATGVFLKSWV | 376 | O75807 | |
| SQLSKWPGSPTSRSS | 286 | O43524 | |
| PGASQAWTKATESSS | 756 | Q2M3C7 | |
| AWTKATESSSSSPLS | 761 | Q2M3C7 | |
| SKTENSWGEPSSPST | 811 | Q9HCJ0 | |
| IKSTWSSGPTSHTQA | 1441 | Q9HCJ0 | |
| QPSTSLLANTSWTGT | 6 | Q9GZN6 | |
| SSGPASVSQLSSWKT | 426 | Q3ZLR7 | |
| PRPWQSSTSTGESSK | 486 | B4DYI2 | |
| LSSSNKSPSSAWSSS | 1176 | Q9P212 | |
| ATPSSSNGQKSLGLW | 666 | A6NI28 | |
| PSPWQSSTSTGESSK | 636 | Q5VVP1 | |
| PSNSLTWGTNASSSS | 1401 | Q8IVL1 | |
| TWGTNASSSSAVSKD | 1406 | Q8IVL1 | |
| SSTKNIWVSGLSSNT | 381 | Q9NWH9 | |
| KPRPWQSSTSTGESS | 491 | P0DKV0 | |
| SSGPASVSQLSSWKT | 426 | P0C7V6 | |
| STQKSGLDSVSSWLP | 86 | Q6PD74 | |
| SSKWSTANPSTVAGR | 336 | O75122 | |
| SCSSWGTGSTNKNLP | 16 | A0AVT1 | |
| TWSPQSSSGSAVLSA | 326 | Q8TCW7 | |
| DGTWPRQTLQSKSST | 221 | Q13107 | |
| STTSNTTFLGLKWTN | 261 | O15455 | |
| TTSSWDMGSTTQSPS | 386 | Q14157 | |
| STASGSIPLSAFWSA | 651 | Q5VZP5 | |
| THPWASSGVSILSSS | 336 | O95155 | |
| SPSEKNSSFTWSVPS | 241 | Q2TAL5 | |
| SLTTSPSSSSLDTWG | 331 | O94885 | |
| NGWTLSCSLPSSSVS | 396 | Q68DE3 | |
| AASPSWLDTLKFSTT | 346 | Q5SNT2 | |
| WKVLSSSGSEAAVPS | 976 | Q15149 | |
| LGWVSSSSPTSSASS | 26 | Q13641 | |
| MSSTSSKAESTWGPS | 841 | Q8NEE8 | |
| SWVASSPSSKDVASP | 101 | Q2M1K9 | |
| TAIPSWSANSSVAGS | 766 | Q70CQ4 | |
| SPKSLAFTSSIFGSW | 1016 | O43314 | |
| NSDSKLTWSPGSVTN | 1696 | Q8NDV7 | |
| NWSKGRSPSSTLGLS | 41 | Q8N9W7 | |
| NWSKGRSPSSTLGLS | 41 | A6NDX4 | |
| WSTTSGTFPTSAVAQ | 296 | Q92692 |